Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Auxogyn completes $20mm Series A venture round

Executive Summary

Auxogyn Inc. completed its Series A venture round, bringing in a total of $20mm. The first tranche closed in May 2010 with funding from Kleiner Perkins Caufield & Byers, TPG, and Merck Serono Ventures (which invested a total of $4mm in the round). The company is developing Early Embryo Viability Assessment (Eeva), a non-invasive system that determines the viability of embryos used during in vitro fertilization procedures.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies